Replies to post #19838 on Bioelectronics Corp (BIEL)

[fuente]

Simpson, theoretically your numbers make sense, aside from the $15 price point; I'm not sure it that is correct or not.

It is possible that big pharma is thinking this as well. It is also possible that they don't think much of BIEL and don't count them as much competition if clearance comes.

Lots of different possibilities. None of the numbers matter without clearance. Multiple clearances (it is going to be multiple or none) increases the potential value of BIEL. How much interest will big pharma have? Hard to guage at this point.

We will see if/wneh clearances come. If they don't come, there still may be significant interest, albeit not at a higher PPS than with clearance.

It's the technology and the patent..not the ability of BIEL to market or sell these products, that is the value here.